Medical device company thatdevelops, manufactures, and commercializes medical devices used in ultrafiltration therapy.
Nuwellis, Inc. is a distinguished medical device company specializing in the development, manufacturing, and global distribution of innovative products for ultrafiltration therapy. The company's flagship offerings, the Aquadex FlexFlow and Aquadex SmartFlow systems, are pivotal in treating patients suffering from fluid overload who have not responded adequately to diuretic therapy. The Aquadex FlexFlow system comprises a console, disposable blood set, and catheter, designed to provide effective and precise fluid management solutions.
Headquartered in Eden Prairie, Minnesota, Nuwellis markets its products directly to hospitals and clinics across the United States through a dedicated salesforce. Internationally, the company leverages a network of independent specialty distributors spanning key markets in Europe, Asia, and the Middle East, including Austria, Brazil, India, Israel, and the United Kingdom. This strategic approach ensures broad accessibility to its advanced medical technologies, supporting healthcare providers worldwide in delivering optimal patient care.
Founded in 1999 and formerly known as CHF Solutions, Inc., Nuwellis rebranded in April 2021 to reflect its expanded focus and commitment to advancing ultrafiltration therapy solutions. With a strong foundation in research and development, Nuwellis continues to drive innovation in medical devices, aiming to enhance patient outcomes and quality of life globally.